Analystreport

Bellus Health Inc. (NYSE: BLU) had its "buy" rating re-affirmed by analysts at Ci Capital. They now have a $7.00 price target on the stock.

BELLUS Health Inc. - Common Shares  (BLU) 
Last bellus health inc. - common shares earnings: 11/14 07:00 am Check Earnings Report